REGULATED PRESS RELEASE published on 07/29/2024 at 17:45, 3 months 25 days ago Disclosure of trading in own shares from July 22th, 2024, to July 26th, 2024. Detailed information per transaction Lagardère SA discloses trading in own shares from July 22nd, 2024, to July 26th, 2024, through detailed transactions with BNP Paribas SA. Shares allocated to employees Lagardère SA Trading Own Shares Employees BNP Paribas SA
BRIEF published on 07/23/2024 at 17:40, 4 months ago Lagardère Group Reports First-Half 2024 Results Revenue Growth LAGARDERE Recurring EBIT First-Half 2024 Publishing And Retail
BRIEF published on 07/23/2024 at 17:40, 4 months ago Lagardère Publishes 2024 Interim Financial Report Financial Statements AMF 2024 LAGARDERE Interim Financial Report
REGULATED PRESS RELEASE published on 07/23/2024 at 17:35, 4 months ago First-Half 2024 Results Lagardère group reports double-digit revenue growth and record recurring EBIT in the first half of 2024 across all businesses. Chairman Arnaud Lagardère highlights strong performances in Publishing and Travel Retail Revenue Growth Business Performance LAGARDERE Arnaud Lagardère Recurring EBIT
REGULATED PRESS RELEASE published on 07/23/2024 at 17:35, 4 months ago PUBLICATION OF THE INTERIM FINANCIAL REPORT AS OF 30 JUNE 2024 Lagardère SA releases 2024 Interim Financial Report as of 30 June 2024, now available on website. Includes activity report and financial statements Lagardère SA AMF 2024 French Financial Markets Interim Financial Report
BRIEF published on 07/15/2024 at 17:50, 4 months 8 days ago Lagardère SA Announces Share Buyback Activity from July 8th to July 12th, 2024 Share Buyback LAGARDERE July 2024 Trading Activity
REGULATED PRESS RELEASE published on 07/15/2024 at 17:45, 4 months 8 days ago Disclosure of trading in own shares from July 8th, 2024, to July 12th, 2024 Lagardère SA discloses trading in own shares from July 8th to July 12th, 2024, involving 16,631 shares with a weighted average price of €21.8127 per share Lagardère SA Trading Disclosure Own Shares Weighted Average Price
REGULATED PRESS RELEASE published on 07/15/2024 at 17:45, 4 months 8 days ago Disclosure of trading in own shares from July 8th, 2024, to July 12th, 2024. Detailed information per transaction
BRIEF published on 07/09/2024 at 17:50, 4 months 14 days ago LAGARDERE SA Announces Half-Year Liquidity Contract Statement Liquidity Contract Half-year Statement Lagardère SA BNP Paribas Financial Markets
REGULATED PRESS RELEASE published on 07/09/2024 at 17:45, 4 months 14 days ago Half-year liquidity contract statement LAGARDERE SA announces first half of 2024 liquidity contract details with BNP PARIBAS FINANCIAL MARKETS as per French Financial Markets Authority decision n° 2021-01 Liquidity Contract Lagardère SA French Financial Markets Authority Financial Report BNP PARIBAS FINANCIAL MARKETS
Published on 11/22/2024 at 23:55, 1 day 3 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 3 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 3 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 4 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 8 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 9 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 10 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 2 days 20 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 7 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 9 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 9 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
